Anna U Loengard insider trades

Open-market stock purchases and sales by Anna U Loengard, Director at Clover Health Investments, Corp /DE, from SEC Form 4 filings since Nov 28, 2022.

Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +173%.

Recent trades

DateStockTradeValue
Jan 6, 2026CLOV Clover Health Investments, Corp /DEBought (not open market)—

Companies traded

  • CLOV Clover Health Investments, Corp /DE: 9 buys, last Jan 6, 2026

Get free alerts when Anna U Loengard files a new trade →